These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24261365)

  • 1. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
    Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
    AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results.
    Rosenkrantz AB; Haghighi M; Horn J; Naik M; Hardie AD; Somberg MB; Melamed J; Xiao GQ; Huang WC; Taouli B
    AJR Am J Roentgenol; 2013 Dec; 201(6):1254-9. PubMed ID: 24261364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
    Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI.
    Akita H; Jinzaki M; Kikuchi E; Sugiura H; Akita A; Mikami S; Kuribayashi S
    AJR Am J Roentgenol; 2011 Nov; 197(5):1130-6. PubMed ID: 22021505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA; Kim CK; Park SY; Cho SW; Park BK
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
    Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
    AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
    Rosenkrantz AB; Wehrli NE; Melamed J; Taneja SS; Shaikh MB
    Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.
    Rheinheimer S; Stieltjes B; Schneider F; Simon D; Pahernik S; Kauczor HU; Hallscheidt P
    Eur J Radiol; 2012 Mar; 81(3):e310-6. PubMed ID: 22104090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
    Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
    AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
    Wang HJ; Pui MH; Guo Y; Li SR; Guan J; Zhang XL; Cai HS
    AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
    Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
    Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma.
    Maruyama M; Yoshizako T; Uchida K; Araki H; Tamaki Y; Ishikawa N; Shiina H; Kitagaki H
    Acta Radiol; 2015 Feb; 56(2):250-6. PubMed ID: 24518687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotumours in chronic kidney disease: can diffusion-weighted MRI rule out malignancy.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A
    Eur J Radiol; 2013 Nov; 82(11):1870-6. PubMed ID: 23932396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
    Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
    Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
    Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM
    AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
    Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
    AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.